Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

The new compound may be a safer alternative to finasteride for prostate protection.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Dutasteride may reduce insulin sensitivity and increase body fat.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Certain medications, especially Paroxetine, Tamsulosin, and Finasteride, are linked to ejaculatory disorders.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Finasteride treatment increased blood volume and reduced vessel leakiness in beagle prostates.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Finasteride helps improve treatment for benign prostatic hyperplasia.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.